Fate Therapeutics, Inc. (FATE)

NASDAQ: FATE · Real-Time Price · USD

1.350

+0.060 (4.65%)

At close: Oct 31, 2025, 4:00 PM EDT

1.390

+0.040 (2.96%)

After-hours: Oct 31, 2025, 5:05 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2010 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2010 - 2019
Cellular Immunotherapies	13.63M	Log In	Log In	Log In	Log In	Upgrade
Cellular Immunotherapies Growth	-78.55%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2010 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2010 - 2019
United States	13.63M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-78.55%	Log In	Log In	Log In	Log In	Upgrade